NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
New Ray Medicine International Holding Limited新銳醫藥國際控股有限公司
(Incorporated in Bermuda with limited liability)
(Stock Code: 6108) DATE OF BOARD MEETINGThe board ("Board") of directors ("Directors") of New Ray Medicine International Holding Limited ("Company") announces that a meeting of the Board will be held on Tuesday, 29 August 2017 for the purposes of, among other matters, considering and approving the unaudited interim results of the Company and its subsidiaries for the six months ended 30 June 2017 and its publication thereof, and considering the payment of dividend, if any.
On behalf of the Board
New Ray Medicine International Holding Limited Zhou LingChairman & Executive Director
Hong Kong, 17 August 2017
As of the date of this announcement, the executive Directors are Mr. Zhou Ling and Ms. Yang Fang; and the independent non-executive Directors are Mr. Ho Hau Cheung, SBS, MH, Mr. Leung Chi Kin and Ms. Li Sin Ming, Ivy.
New Ray Medicine International Holding Ltd. published this content on 17 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 August 2017 01:26:03 UTC.
Original documenthttp://www.newraymedicine.com/PublicSite/files/LTN20170817889.pdf
Public permalinkhttp://www.publicnow.com/view/828639D10EC1180F6CCB1044BAB4372820F7E764
